Impact of Aging on Cranial Anatomy and Neurological Function

Introduction

Aging in the context of cranial anatomy and neurological function refers to the progressive decline in tissue function that occurs over time, leading to a decrease in physical and mental capacity and an increased risk of disease [1]. The brain plays a crucial role in aging, as neurodegenerative diseases are the most debilitating disorders in older individuals [2]. Aging affects various aspects of neurological function, including cerebrovascular function, which is impaired in aging and is associated with increased risk of Alzheimer’s disease (AD) [3]. Structural changes in the brain also occur with aging, such as decrease in regional cortical volume and an increase in cerebrospinal fluid compartments [4].

The impact of aging on cranial anatomy and neurological function is observed across a wide age range. Morphological changes in the brain, such as reduction in cortical volume and thickness, are found in individuals as young as 20-40 years old [5]. These changes become more pronounced after the age of 40-50 years, leading to functional manifestations such as weakened sensory-motor and cognitive abilities [6]. Additionally, age-related changes in the number of nerve cells occur in different parts of the brain [7].

Understanding age-related changes in cranial anatomy and neurological function is crucial for both healthcare and research purposes. Age-related changes in the brain, such as alterations in cerebral vasculature and neurovascular coupling, can negatively impact cognition and contribute to age-related disorders like stroke and dementia [8]. These changes can affect the supply of oxygen and glucose to neurons, leading to cognitive decline [9]. Additionally, age-related structural and functional modifications in the nervous system can result in clinical abnormalities that can be detected during a neurological examination [10]. Knowledge of these changes can help neuroanesthesiologists better understand the implications of anesthesia in elderly neurosurgical patients [11]. Furthermore, understanding the effects of aging on the cerebro-vasculature is crucial for interpreting blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) in cognitive neuroscience research. Understanding age-related changes in cranial anatomy and neurological function is essential for improving healthcare outcomes and advancing research in the field.

The primary goal of the review is to examine the interplay between aging, cranial anatomy, and neurological function, with a focus on understanding the physiological changes that occur with age and their implications for neurological health. We’ll cover age-related changes in cranial anatomy, including decreased bone density, alterations in shape, and closure of sutures and fontanelles. We’ll also touch on changes in cranial blood vessels, cerebrospinal fluid dynamics, and circulation. Regarding neurological effects, we’ll discuss brain volume loss, ventricular enlargement, and grey and white matter changes. We’ll explore neurotransmitter alterations, synaptic dysfunction, and their impact on cognitive function and memory. . Furthermore, the article seeks to explore the clinical implications of these changes, particularly in terms of increased susceptibility to neurodegenerative disorders like Alzheimer’s and Parkinson’s, and the challenges of diagnosis and management. Lastly, a touch on future research directions, focusing on neuroimaging advancements and potential therapies for age-related neurodegeneration.

Impact of Aging on Cranial Anatomy

Aging has a profound impact on cognitive function, memory, and sensory processing, with various physiological and pathological changes contributing to these neurological consequences. The electrophysiological activity of the brain and nervous system changes with age, leading to derangement of neural and cognitive functions [12]. Structural and functional changes occur in the brain and spinal cord, including cerebral atrophy, neuronal loss and decreased neurotransmitters which can affect cognition, sensory, and affective processes [13]. Disorders of the sensory systems, such as vision and hearing, are often associated with cognitive impairment and may be early symptoms of neurodegenerative diseases [14]. Peripheral immunological challenges can cause cognitive decline in older individuals, and neuroinflammatory priming in the aged brain can lead to exaggerated neuroimmune responses and cognitive impairment [15]. Age-related changes in the olfactory, visual, auditory, and motor systems may precede cognitive symptoms of Alzheimer’s disease and increase the risk of developing Alzheimer’s disease [16].

Brain volume loss and ventricular enlargement are both neurological consequences of aging. Age-related changes in brain structure, such as atrophy of the brain parenchyma and white matter changes, can lead to enlargement of the ventricles [17]. Ventricular volume (VV) is a powerful indicator of brain tissue loss in normal aging and dementia, and patterns of thinner cortical gray matter have been associated with dynamic changes in ventricular volume [18]. White matter hyperintensities (WMHs) are also associated with cognitive decline in the normal aging population and in patients with neurodegenerative diseases. White matter hyperintensities (WMHs) can be detected using various imaging techniques. One such technique is myelin water imaging, which provides specific markers of myelin content and interstitial fluid [19]. Another technique is mask region-based convolutional neural network (CNN) method, which uses magnetic resonance (MR) scans to automatically detect WMHs [20]. Cerebral atrophy, characterized by brain shrinking and enlargement of fluid- filled spaces, is a hallmark of normal aging and can affect brain biomechanics during head impact [21]. Brain shrinkage and ventricular expansion are highly heterogeneous, with the largest changes seen in the frontal and temporal cortex, putamen, thalamus, and accumbens [22]. Ventriculomegaly, the expansion of brain ventricles, is commonly found in the aging brain and is associated with cognitive impairment and abnormal protein accumulation [23].

Neurological Consequences of Aging

Aging is also associated with alterations in neurotransmitter function and synaptic dysfunction, leading to cognitive decline and memory dysfunction [24]. With advancing age, the intricate web of neurotransmitter interactions experiences shifts, particularly evident in the transmission of excitatory signals mediated by glutamate and its receptors. This alteration stems from changes in the brain’s chemical equilibrium and energy production mechanisms as the aging process progresses [25]. Furthermore, the aging brain experiences diminished efficacy in intercellular communication, leading to compromised synaptic transmission. This decline manifests prominently in regions like the hippocampus, impacting the consolidation of long-term memories [26]. The dwindling levels of dopamine, a neurotransmitter crucial for cognitive function, contribute to age-related cognitive decline [27].

In neurodegenerative disorders such as Alzheimer’s disease, disruptions in brain communication mechanisms are characterized by the accumulation of specific protein like amyloid-beta (Aβ) peptide which is responsible for the oligomerization and aggregation of Aβ into protein plaques in the brain [28] and results in alterations in neuronal functioning [29]. The diagnostic test for Alzheimer’s disease involves detecting and quantifying Aβ peptide using solid supports coated with heavy metal cations such as zinc (II) or copper (II) form of a nitriloacetic acid [30]. These observations underscore the intricate interplay between changes in neurotransmitter dynamics and synaptic communication in shaping cognitive processes during the aging process.

Clinical Implications and Challenge

As individuals progress through the aging process, their susceptibility to developing neurodegenerative conditions, exemplified by Alzheimer’s disease and Parkinson’s disease, undergoes a notable increase [31, 32]. Aging represents a complex interplay of various molecular and cellular processes intricately implicated in neurodegeneration, encompassing a broad spectrum of phenomena such as protein aggregation, inflammatory cascades, and metabolic dysregulation. Moreover, the accumulation and aggregation of pathological conformations of endogenous proteins, which are typically cleared via the lymphatic system, significantly contribute to the multifaceted pathogenesis of neurodegenerative diseases, thereby underscoring the intricate nature of age- related neurological disorders [33].

Diagnosing age-related neurological conditions poses significant challenges due to several factors inherent to the aging process. Firstly, the presentation of neurological symptoms in older adults can be complex and heterogeneous, often overlapping with age-related cognitive decline or comorbidities, complicating accurate diagnosis [34]. Moreover, the subtle onset and progression of symptoms in conditions such as Alzheimer’s disease and Parkinson’s disease can make early detection challenging, particularly in the absence of specific biomarkers or definitive diagnostic tests [35]. Additionally, age-related changes in sensory perception, such as vision and hearing impairments, may further obscure symptomatology and hinder accurate clinical assessment. Moreover, the coexistence of numerous chronic conditions and medications among older adults can complicate diagnostic assessments, requiring thorough interdisciplinary evaluations to distinguish between age-related changes and pathological conditions. This is particularly important in primary care settings, where dementia is often underdiagnosed and misdiagnosed due to competing clinical concerns [36]. Delayed diagnosis and care of dementia can lead to more rapid cognitive decline, increased hospitalizations, healthcare costs, and mortality [37]. Additionally, certain elderly populations face challenges in accessing specialized healthcare services and resources, potentially leading to delays in diagnosis and the implementation of appropriate management strategies [38].

Management strategies and interventions for promoting healthy brain aging encompass a multifaceted approach aimed at preserving cognitive function and mitigating age-related neurological decline. Lifestyle modifications, including regular physical exercise, healthy diet, adequate sleep, and cognitive stimulation through activities such as puzzles, reading, and social interaction, have been shown to support brain health and resilience. Additionally, managing cardiovascular risk factors such as hypertension, diabetes, and hypercholesterolemia through pharmacological and non-pharmacological interventions can help reduce the risk of cerebrovascular disease and cognitive impairment [39]. Other strategies currently being explored include caloric restriction, ketogenic diet, promotion of cellular nicotinamide adenine dinucleotide (NAD+) levels, removal of senescent cells, ‘young blood’ transfusions, enhancement of adult neurogenesis, stem cell therapy, and vascular risk reduction [40]. However, clinical evidence for these strategies is limited, and further studies are needed to determine their long-term efficacy and potential adverse effects.

Future Direction and Research Opportunities

The exploration of future directions and research opportunities in age-related neurological changes is crucial for advancing our understanding and developing effective interventions. Firstly, the continual refinement and adoption of neuroimaging techniques present an exciting frontier in elucidating age-related alterations in brain structure and function with unprecedented precision. Neuroimaging techniques like functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), and positron emission tomography (PET) offer unprecedented precision in elucidating age-related alterations such as subtle changes in neural connectivity, synaptic plasticity, and neurochemical dynamics in brain structure and function [41, 42]. Identifying therapeutic targets for preventing or slowing down age- related neurodegeneration is a critical focus, with promising pharmacological agents targeting neuroinflammation, oxidative stress, protein aggregation, and mitochondrial dysfunction [43, 44]. Interdisciplinary collaboration among neuroscientists, anatomists, clinicians, and geneticists is essential in unraveling the multifactorial determinants of age-related neurological decline .By harnessing collective expertise and resources across various disciplines, interdisciplinary research holds the key to uncovering novel insights into the mechanisms underlying healthy brain aging and informing the development of personalized interventions tailored to individual needs [45]. Embracing these opportunities is crucial for advancing knowledge of age-related neurological changes and enhancing the quality of life for aging populations worldwide.

Discussion

Age-related changes in cranial anatomy involve various aspects of the skull and brain. The brain undergoes volume decline with age, particularly in the frontal cortex, temporal areas, posterior association areas, and occipital areas [46]. As individuals progress through the aging process, they undergo significant transformations in the cranial anatomy, which have profound implications in neurological function [47]. Among these changes, a prominent one is the decline in bone density coupled with alterations in cranial shape, often resulting in structural adjustments [48]. Moreover, the natural progression of ossification and the closure of cranial sutures and fontanelles further contribute to the overall rigidity of the skull as one ages. Simultaneously, there are noteworthy modifications in cranial blood vessels and their supply to the brain, potentially impacting cerebral perfusion and metabolic requirements [49]. Additionally, age-related shifts in cerebrospinal fluid dynamics and circulation play a pivotal role in sustaining optimal brain function. These alterations can significantly influence the regulation of intracranial pressure, as well as the exchange of nutrients and waste, thus maintaining overall brain homeostasis.

Conclusion

In conclusion, the exploration of age-related changes in cranial anatomy and neurological function sheds light on the intricate interplay between aging and brain health. As individuals age, they undergo significant transformations in cranial structure and neural function, with profound implications for cognitive health and neurological disorders. Understanding these age-related alterations is imperative for both healthcare and research purposes. Age-related changes in the brain, such as alterations in cerebral vasculature and neurotransmitter dynamics, can impact cognition and increase the risk of neurological disorders like Alzheimer’s disease and Parkinson’s disease. However, challenges in diagnosing age-related neurological conditions, including the complexity of symptoms and comorbidities, highlight the need for comprehensive interdisciplinary assessments and improved access to specialized healthcare services for older adults. Moving forward, future research directions offer promising opportunities for advancing our understanding and developing effective interventions. Advances in neuroimaging techniques, identification of therapeutic targets, and interdisciplinary collaboration hold the key to unraveling the mechanisms underlying healthy brain aging and improving outcomes for aging populations worldwide. By embracing these opportunities, we can pave the way for transformative advancements in aging research and ultimately enhance the quality of life for older adults.

Source of Funding

None

Conflict of Interest

None